TG Therapeutics Inc (TGTX) — Cash Flow Quality Index
TG Therapeutics Inc (TGTX) has a Cash Flow Quality Index of -0.90x as of March 2026. Operating cash flow of $-17.89 Million is below net income of $19.78 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of TG Therapeutics Inc to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
TG Therapeutics Inc Cash Flow Quality Index (2010–2025)
Historical Cash Flow Quality Index for TG Therapeutics Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check TGTX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for TG Therapeutics Inc (2010–2025)
Year-by-year earnings quality comparison for TG Therapeutics Inc. For live market cap and the full company financial profile, see TG Therapeutics Inc (TGTX) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.06x | $-24.77 Million | $447.18 Million | ▲ +96.8% |
| 2024 | -1.73x | $-40.52 Million | $23.38 Million | ▲ +30.1% |
| 2023 | -2.48x | $-31.41 Million | $12.67 Million | ▲ +21.5% |
| 2010 | -3.16x | $-1.97 Million | $623.64K | — |